Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
McPhillips, Mike A.
and
Barnes, Thomas R.E.
1997.
Negative symptoms.
Current Opinion in Psychiatry,
Vol. 10,
Issue. 1,
p.
30.
Owens, David G. C.
Finlayson, Alan
Mercer, Gavin
and
Johnstone, Eve C.
1997.
The use of videotaped assessment in relation to a study of enhanced management in treatment-resistant schizophrenia.
Journal of Psychopharmacology,
Vol. 11,
Issue. 4,
p.
357.
Gerbaldo, H.
1997.
Negativsymptomatik.
p.
45.
Malla, Ashok K.
Norman, Ross M.G.
Kotteda, Vinod
and
Zirul, Sandra
1999.
Switching from therapy with typical antipsychotic agents to risperidone: Long-term impact on patient outcome.
Clinical Therapeutics,
Vol. 21,
Issue. 5,
p.
806.
Krystal, John H
D'Souza, D.Cyril
Madonick, Steven
and
Petrakis, Ismene L
1999.
Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients.
Schizophrenia Research,
Vol. 35,
Issue. ,
p.
S35.
Fleischhacker, W. W.
1999.
Search for the Causes of Schizophrenia.
p.
331.
Tandon, Rajiv
DeQuardo, John R
Taylor, Stephan F
McGrath, Marlene
Jibson, Michael
Eiser, Alan
and
Goldman, Mona
2000.
Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome.
Schizophrenia Research,
Vol. 45,
Issue. 3,
p.
191.
Arango, Celso
Kirkpatrick, Brian
and
Buchanan, Robert W.
2000.
Neurological Signs and the Heterogeneity of Schizophrenia.
American Journal of Psychiatry,
Vol. 157,
Issue. 4,
p.
560.
Fleischhacker, W. W.
2000.
Psychiatrie der Gegenwart 5.
p.
209.
Berardi, Domenico
Giannelli, Annalisa
Biscione, Roberto
and
Ferrari, Giuseppe
2000.
Extrapyramidal symptoms and residual psychopathology with low-dose neuroleptics.
Human Psychopharmacology: Clinical and Experimental,
Vol. 15,
Issue. 2,
p.
79.
Moritz, S.
Andresen, B.
Jacobsen, D.
Mersmann, K.
Wilke, U.
Lambert, M.
Naber, D.
and
Krausz, M.
2001.
Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics.
European Psychiatry,
Vol. 16,
Issue. 6,
p.
354.
Fleischhacker, W. W.
2001.
Contemporary Psychiatry.
p.
1509.
Eltayb, Amani
Wadenberg, Marie-Louise G.
Schilström, Björn
and
Svensson, Torgny H.
2005.
Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride.
Naunyn-Schmiedeberg's Archives of Pharmacology,
Vol. 372,
Issue. 3,
p.
195.
2005.
The Maudsley 2005-2006 Prescribing Guidelines.
p.
7.
Eltayb, Amani
Wadenberg, Marie-Louise G.
and
Svensson, Torgny H.
2005.
Enhanced Cortical Dopamine Output and Antipsychotic-like Effect of Raclopride with Adjunctive Low-Dose L-dopa.
Biological Psychiatry,
Vol. 58,
Issue. 4,
p.
337.
Quednow, Boris B.
Wagner, Michael
Westheide, Jens
Beckmann, Katrin
Bliesener, Niclaas
Maier, Wolfgang
and
Kühn, Kai-Uwe
2006.
Sensorimotor Gating and Habituation of the Startle Response in Schizophrenic Patients Randomly Treated With Amisulpride or Olanzapine.
Biological Psychiatry,
Vol. 59,
Issue. 6,
p.
536.
Seethalakshmi, R.
Parkar, S.R.
Nair, N.
and
Pandit, A.G.
2006.
Increased Thalamostriatal-Mesiotemporal Glucose Uptake with Symptom Remission in Schizophrenia-A Case Report.
The Journal of ECT,
Vol. 22,
Issue. 1,
p.
74.
Murphy, Brendan P.
Chung, Young-Chul
Park, Tae-Won
and
McGorry, Patrick D.
2006.
Pharmacological treatment of primary negative symptoms in schizophrenia: A systematic review.
Schizophrenia Research,
Vol. 88,
Issue. 1-3,
p.
5.
Ruhrmann, Stephan
Kissling, Werner
Lesch, Otto-Michael
Schmauss, Max
Seemann, Ute
and
Philipp, Michael
2007.
Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 31,
Issue. 5,
p.
1012.
2009.
The Maudsley Prescribing Guidelines, Tenth Edition.
p.
9.
eLetters
No eLetters have been published for this article.